LAMB2 and metabolic dysfunction-associated steatohepatitis: Taken together, currently our results have identified several new pathological molecules secreted by aHSCs that are involved in diabetes-related MAFLD and even NASH, including Lamb2 and Tgfb1i1. These findings merit further research and exploration as potential targets for preventing severe liver fibrosis.